MKM Partners Initiated Stock Coverage on This BioPharma Company Today Wall St. Cheat Sheet The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. (Note: Selected financial data are sourced from Briefing.com via ... |
